DK175216B1 - Dihydropyridinformulering med forlænget frigivelse og fremstilling heraf - Google Patents
Dihydropyridinformulering med forlænget frigivelse og fremstilling heraf Download PDFInfo
- Publication number
- DK175216B1 DK175216B1 DK198700477A DK47787A DK175216B1 DK 175216 B1 DK175216 B1 DK 175216B1 DK 198700477 A DK198700477 A DK 198700477A DK 47787 A DK47787 A DK 47787A DK 175216 B1 DK175216 B1 DK 175216B1
- Authority
- DK
- Denmark
- Prior art keywords
- calcium channel
- alkyl
- acting
- pharmaceutical composition
- long
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82389686A | 1986-01-30 | 1986-01-30 | |
| US82389686 | 1986-01-30 | ||
| US94087886A | 1986-12-10 | 1986-12-10 | |
| US94087886 | 1986-12-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK47787D0 DK47787D0 (da) | 1987-01-29 |
| DK47787A DK47787A (da) | 1987-07-31 |
| DK175216B1 true DK175216B1 (da) | 2004-07-12 |
Family
ID=27124769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198700477A DK175216B1 (da) | 1986-01-30 | 1987-01-29 | Dihydropyridinformulering med forlænget frigivelse og fremstilling heraf |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0231026B1 (es) |
| JP (1) | JP2524990B2 (es) |
| KR (1) | KR900005009B1 (es) |
| AU (1) | AU604672B2 (es) |
| CA (1) | CA1285227C (es) |
| DE (1) | DE3782439T2 (es) |
| DK (1) | DK175216B1 (es) |
| ES (1) | ES2052500T3 (es) |
| FI (1) | FI88872C (es) |
| GR (1) | GR3006148T3 (es) |
| HU (1) | HU196709B (es) |
| IE (1) | IE61879B1 (es) |
| IL (2) | IL81419A0 (es) |
| IT (1) | IT1206876B (es) |
| NO (1) | NO174325C (es) |
| NZ (1) | NZ219090A (es) |
| PH (1) | PH26366A (es) |
| PT (1) | PT84213B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4940556A (en) * | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
| IE63321B1 (en) * | 1986-02-03 | 1995-04-05 | Elan Corp Plc | Drug delivery system |
| GB2209669B (en) * | 1987-09-11 | 1992-02-12 | Squibb & Sons Inc | Pharmaceutical composition containing high drug load and method for preparing same |
| JP2528706B2 (ja) * | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
| US4925676A (en) * | 1989-02-02 | 1990-05-15 | Warner-Lambert Company | Extended release gemfibrozil composition |
| HU203041B (en) * | 1989-03-14 | 1991-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin |
| JPH0729926B2 (ja) * | 1989-07-25 | 1995-04-05 | 大塚製薬株式会社 | 易吸収性製剤用組成物 |
| CA2126441C (en) * | 1991-12-30 | 1999-12-21 | David F. Erkoboni | Microcrystalline cellulose spheronization composition |
| EP0557064B1 (en) * | 1992-02-20 | 1997-06-11 | Euroceltique S.A. | Modified release formulation |
| GB9203689D0 (en) * | 1992-02-20 | 1992-04-08 | Euro Celtique Sa | Pharmaceutical composition |
| TW474824B (en) * | 1996-09-13 | 2002-02-01 | Basf Ag | The production of solid pharmaceutical forms |
| US6479496B1 (en) * | 1998-09-10 | 2002-11-12 | Cv Therapeutics, Inc. | Methods for treating angina with ranolazine |
| US6303607B1 (en) * | 1998-09-10 | 2001-10-16 | Cv Therapeutics, Inc. | Method for administering a sustained release ranolanolazine formulation |
| EP1970052A2 (en) | 1999-02-09 | 2008-09-17 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
| US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| AU2005320547B2 (en) | 2004-12-27 | 2009-02-05 | Eisai R & D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
| JPS5846019A (ja) * | 1981-09-14 | 1983-03-17 | Kanebo Ltd | 持続性ニフエジピン製剤 |
| FR2581541B1 (fr) * | 1985-05-09 | 1988-05-20 | Rhone Poulenc Sante | Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation |
-
1986
- 1986-01-29 IL IL81419A patent/IL81419A0/xx unknown
-
1987
- 1987-01-26 CA CA000528174A patent/CA1285227C/en not_active Expired - Lifetime
- 1987-01-26 PH PH34763A patent/PH26366A/en unknown
- 1987-01-28 KR KR1019870000682A patent/KR900005009B1/ko not_active IP Right Cessation
- 1987-01-29 IT IT8767057A patent/IT1206876B/it active
- 1987-01-29 IL IL81419A patent/IL81419A/xx not_active IP Right Cessation
- 1987-01-29 JP JP62021668A patent/JP2524990B2/ja not_active Expired - Lifetime
- 1987-01-29 EP EP87101203A patent/EP0231026B1/en not_active Expired - Lifetime
- 1987-01-29 NZ NZ219090A patent/NZ219090A/en unknown
- 1987-01-29 ES ES87101203T patent/ES2052500T3/es not_active Expired - Lifetime
- 1987-01-29 AU AU68102/87A patent/AU604672B2/en not_active Expired
- 1987-01-29 IE IE22987A patent/IE61879B1/en not_active IP Right Cessation
- 1987-01-29 DE DE8787101203T patent/DE3782439T2/de not_active Expired - Lifetime
- 1987-01-29 HU HU87274A patent/HU196709B/hu unknown
- 1987-01-29 DK DK198700477A patent/DK175216B1/da not_active IP Right Cessation
- 1987-01-29 FI FI870380A patent/FI88872C/fi not_active IP Right Cessation
- 1987-01-29 PT PT84213A patent/PT84213B/pt unknown
- 1987-01-29 NO NO870368A patent/NO174325C/no unknown
-
1992
- 1992-11-05 GR GR920401768T patent/GR3006148T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT42950A (en) | 1987-09-28 |
| NZ219090A (en) | 1990-04-26 |
| ES2052500T3 (es) | 1994-07-16 |
| KR900005009B1 (ko) | 1990-07-16 |
| EP0231026A1 (en) | 1987-08-05 |
| HU196709B (en) | 1989-01-30 |
| DE3782439T2 (de) | 1993-05-19 |
| IL81419A (en) | 1991-07-18 |
| IT8767057A0 (it) | 1987-01-29 |
| AU604672B2 (en) | 1991-01-03 |
| KR870007121A (ko) | 1987-08-17 |
| CA1285227C (en) | 1991-06-25 |
| NO870368L (no) | 1987-07-31 |
| FI870380A (fi) | 1987-07-31 |
| NO870368D0 (no) | 1987-01-29 |
| IE870229L (en) | 1987-07-30 |
| NO174325B (no) | 1994-01-10 |
| FI870380A0 (fi) | 1987-01-29 |
| DK47787A (da) | 1987-07-31 |
| AU6810287A (en) | 1987-08-06 |
| FI88872B (fi) | 1993-04-15 |
| GR3006148T3 (es) | 1993-06-21 |
| FI88872C (fi) | 1993-07-26 |
| DE3782439D1 (de) | 1992-12-10 |
| JPS62252732A (ja) | 1987-11-04 |
| EP0231026B1 (en) | 1992-11-04 |
| NO174325C (no) | 1994-04-20 |
| IL81419A0 (en) | 1987-08-31 |
| DK47787D0 (da) | 1987-01-29 |
| IE61879B1 (en) | 1994-11-30 |
| PT84213B (pt) | 1989-03-30 |
| PT84213A (en) | 1987-02-01 |
| IT1206876B (it) | 1989-05-11 |
| PH26366A (en) | 1992-06-01 |
| JP2524990B2 (ja) | 1996-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4940556A (en) | Method of preparing long acting formulation | |
| US5198226A (en) | Long acting nicardipine hydrochloride formulation | |
| DK175216B1 (da) | Dihydropyridinformulering med forlænget frigivelse og fremstilling heraf | |
| US5209933A (en) | Long acting calcium channel blocker composition | |
| JP2637981B2 (ja) | 吸収制御薬剤組成物 | |
| FI93422C (fi) | Menetelmä oraalisen, hapossa pysymätöntä bentsimidatsolijohdannaista sisältävän valmisteen valmistamiseksi | |
| CA2343376C (en) | Sustained release ranolazine formulations | |
| CA2791171C (en) | Apixaban formulations | |
| US4942040A (en) | Pharmaceutical preparation and a process for its preparation | |
| PT1689370E (pt) | Método para a preparação de uma composição farmacêutica sólida para administração oral | |
| JP2009532462A (ja) | 調節放出クロピドグレル製剤 | |
| JP3110794B2 (ja) | １，４−ジヒドロピリジン誘導体を含有する製剤 | |
| WO1989002738A1 (en) | Sustained-release nifedipine formulation | |
| CA2374039C (en) | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations | |
| PT1441700E (pt) | Método para a preparação de uma composição compreendendo ácido 5-aminosalicílico para uso em tratamento de colites ulcerosas ou da doença de crohn | |
| BR112014020184B1 (pt) | Preparação farmacêutica que contém anlodipina e ra-mipril | |
| BR112013003158B1 (pt) | composições farmacêuticas de antagonistas do receptor glutamato metabotrópico 5 (mglu5) | |
| BR112019015107A2 (pt) | Formulação de complexo compreendendo inibidor de hmg-coa redutase e clopidogrel | |
| JPWO2002060448A1 (ja) | 医薬組成物 | |
| IE990406A1 (en) | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. | |
| JPH11171769A (ja) | ３−イソブチリル−２−イソプロピルピラゾロ〔１，５−ａ〕ピリジンの徐放性製剤及びその製法 | |
| AU2017228681B2 (en) | Apixaban formulations | |
| JPH10167966A (ja) | 経口持続性製剤 | |
| JP2001513100A (ja) | デクスフェンフルラミンのプログラムされた放出のための製薬学的組成物 | |
| IE60929B1 (en) | Controlled absorption diltiazem formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |